Launching for the very first time, the Neurodevelopmental Drug Development Summit is the industry's first and only meeting focused on advancing symptomatic and disease modifying treatments across neurodevelopmental disorders.

Don’t miss out on your chance to meet this community for the first time at this dedicated forum and join the conversation to discover the intricacies of clinical trial design across various therapeutic modalities, debate the right outcome measures for your specific population, and uncover the most exciting clinical pipelines for the rare neurodevelopmental disorders you are battling with.

Attend this exclusive virtual summit to:

• Establish lasting connections with this dedicated community at the first ever-industry led meeting focused on advancing symptomatic and disease modifying treatments across neurodevelopmental disorders
• Gain an important market update on the progress of neurodevelopmental drug development through pioneering clinical case studies leveraging diverse approaches across gene therapy, gene replacement, ASO’s and small molecules
• Engage in critical discussions with world leading industry and academic experts and discover novel outcome measures that measure incremental change and how the industry is driving design innovation across disease specific clinical trials